Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) clinical trial (NCT03398655). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from VB-111 and paclitaxel?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) clinical trial (NCT03398655). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) clinical trial (NCT03398655). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) clinical trial (NCT03398655). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) clinical trial (NCT03398655). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any travel or logistical considerations I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL) clinical trial (NCT03398655). Contact the study team or your healthcare provider for specific answers.

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

What this study is about

A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)

What this study is about